Using the technology acceptance model to examine acceptance of telemedicine by cancer patients in an ambulatory care setting
…, SW Lim, CHM Tong, JJX Zhou… - Proceedings of …, 2022 - journals.sagepub.com
Background: Telemedicine has demonstrated benefits for cancer patients including the potential
to improve care coordination and patient outcomes. Since June 2020, teleconsultations …
to improve care coordination and patient outcomes. Since June 2020, teleconsultations …
The approved dose of ivermectin alone is not the ideal dose for the treatment of COVID‐19
VD Schmith, J Zhou, LRL Lohmer - Clinical Pharmacology & …, 2020 - Wiley Online Library
Caly et al. reported that ivermectin inhibited severe acute respiratory syndrome‐coronavirus
2 (SARS‐CoV‐2) in vitro for up to 48 hours using ivermectin at 5 μM. The concentration …
2 (SARS‐CoV‐2) in vitro for up to 48 hours using ivermectin at 5 μM. The concentration …
[HTML][HTML] Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations …
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported
from China in January, 2020. SARS-CoV-2 is efficiently transmitted from person to person …
from China in January, 2020. SARS-CoV-2 is efficiently transmitted from person to person …
[HTML][HTML] Attenuated replication and pathogenicity of SARS-CoV-2 B. 1.1. 529 Omicron
The Omicron (B.1.1.529) variant of SARS-CoV-2 emerged in November 2021 and is rapidly
spreading among the human population 1 . Although recent reports reveal that the Omicron …
spreading among the human population 1 . Although recent reports reveal that the Omicron …
Exercise training improves obesity‐related lymphatic dysfunction
…, MD Nitti, JC Gardenier, J Zhou… - The Journal of …, 2016 - Wiley Online Library
… general anaesthesia to baseline and postexercise lymphatic function testing using near-infrared
(NIR) lymphatic imaging with a modification of previously published techniques (Zhou et …
(NIR) lymphatic imaging with a modification of previously published techniques (Zhou et …
Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of …
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging
coronavirus that has resulted in more than 2 000 000 laboratory-confirmed cases including …
coronavirus that has resulted in more than 2 000 000 laboratory-confirmed cases including …
[PDF][PDF] Oral SARS-CoV-2 inoculation establishes subclinical respiratory infection with virus shedding in golden Syrian hamsters
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is transmitted largely by
respiratory droplets or airborne aerosols. Despite being frequently found in the immediate …
respiratory droplets or airborne aerosols. Despite being frequently found in the immediate …
Attenuated interferon and proinflammatory response in SARS-CoV-2–infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation
Clinical manifestations of coronavirus disease 2019 (COVID-19) vary from asymptomatic virus
shedding, nonspecific pharyngitis, to pneumonia with silent hypoxia and respiratory failure…
shedding, nonspecific pharyngitis, to pneumonia with silent hypoxia and respiratory failure…
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA. 1 and BA. 2
…, T Zhu, J Zhang, W Li, AJ Zhang, J Zhou… - Emerging Microbes & …, 2022 - Taylor & Francis
SARS-CoV-2 B.1.1.529.1 (Omicron BA.1) emerged in November 2021 and quickly became
the predominant circulating SARS-CoV-2 variant globally. Omicron BA.1 contains more than …
the predominant circulating SARS-CoV-2 variant globally. Omicron BA.1 contains more than …
[HTML][HTML] Emerging SARS-CoV-2 variants expand species tropism to murines
Background Wildtype mice are not susceptible to SARS-CoV-2 infection. Emerging SARS-CoV-2
variants, including B.1.1.7, B.1.351, P.1, and P.3, contain mutations in spike that has …
variants, including B.1.1.7, B.1.351, P.1, and P.3, contain mutations in spike that has …